# Naproxen Versus Placebo as Adjunct Treatment of Cellulitis

> **NCT07665476** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Ottawa Hospital Research Institute** · enrollment: 884 (estimated)

## Conditions studied

- Cellulitis
- Skin Disease, Infectious
- Infection
- Skin and Soft Tissue Infections (SSTIs)

## Interventions

- **DRUG:** enteric-coated naproxen
- **DRUG:** Cephalexin Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07665476
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2030-12-01
- **Final completion:** 2031-12-01
- **Target enrollment:** 884 (ESTIMATED)
- **Last updated:** 2026-07-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665476, "Naproxen Versus Placebo as Adjunct Treatment of Cellulitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07665476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*